{"schema_version":"secwatch.filing_event.v1","accession":"0001703057-26-000033","form_type":"8-K","ticker":"ABCL","cik":"0001703057","company_name":"AbCellera Biologics Inc.","filed_at":"2026-06-12T16:12:02+00:00","discovered_at":"2026-06-12T16:13:01.446448+00:00","generated_at":"2026-06-12T16:13:11.244052+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AbCellera shareholders elect two Class III directors, ratify EY, approve say-on-pay","bullets":["John S. Montalbano elected with 141.4M for, 12.7M against; Stephen R. Quake with 149.0M for, 5.1M against.","Ratification of Ernst & Young as independent auditor for FY2026: 190.0M for, 0.6M against.","Advisory say-on-pay approved: 142.8M for, 10.9M against, with 36.6M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001703057-26-000033","json":"https://secwatch.observer/filing/0001703057-26-000033.json","markdown":"https://secwatch.observer/filing/0001703057-26-000033.md","text":"https://secwatch.observer/filing/0001703057-26-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000033/0001703057-26-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000033/abcl-20260611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T16:13:11.244052+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38f0112b71f0a760b2dc8a16caa52a1bab959aea","claim":"AbCellera Biologics Inc. shareholders approved Election of John S. Montalbano, CFA, and Stephen R. Quake, D.Phil. as Class III directors at the 2026-06-11 meeting.","evidence_excerpt":"The Company’s shareholders approved the election of John S. Montalbano, CFA, and Stephen R. Quake, D.Phil., as Class III directors recommended for election in Proposal 1 at the Annual Meeting. The Company’s shareholders voted for the Class III directors as follows: Nominee For Against Abstain John S. Montalbano, CFA 141,430,732 12,723,342 45,898 Stephen R. Quake, D.Phil. 149,019,960 5,113,056 66,956 The broker non-votes for this Proposal 1 totaled 36,576,359 common shares.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000033/0001703057-26-000033-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"396c6a290c4303b7ca8becf188d7383e8ed87983","claim":"AbCellera Biologics Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.","evidence_excerpt":"The Company’s shareholders approved Proposal 2. The votes cast at the Annual Meeting were as follows: For Against Abstain 189,927,972 552,429 295,930","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000033/0001703057-26-000033-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"928fe45c2a4f3e89b48eab1952ae529295308070","claim":"AbCellera Biologics Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers (Say-on-Pay) at the 2026-06-11 meeting.","evidence_excerpt":"The Company’s shareholders approved Proposal 3. The votes cast at the Annual Meeting were as follows: For Against Abstain 142,831,950 10,932,105 435,917 The broker non-votes for this Proposal 3 totaled 36,576,359 common shares.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000033/0001703057-26-000033-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}